Walter Reed military scientists testing vaccine that could protect against Omicron, future COVID variants

Col. Wendy Sammons-Jackson, Dr. Nelson Michael,
(Image credit: Win McNamee/Getty Images)

Scientists at the Walter Reed Army Institute of Research spent nearly two years developing a COVID-19 vaccine that should protect people against the new Omicron variant, plus all past SARS-origin viruses, and presumably future coronavirus strains as well, Defense One reports. The Spike Ferritin Nanoparticle (SpFN) vaccine showed promising results in animal trials and Phase 1 human trials that wrapped up this month; it still needs to undergo Phase 2 and Phase 3 human trials.

"We decided to take a look at the long game rather than just only focusing on the original emergence of SARS, and instead understand that viruses mutate, there will be variants that emerge, future viruses that may emerge in terms of new species," Dr. Kayvon Modjarrad, director of Walter Reed's infectious diseases branch, told Defense One. "Our platform and approach will equip people to be prepared for that."

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Sign up
Latest Videos FromThe Week
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.